Immune therapy of a persistent and disseminated viral infection.
about
Therapeutic antiviral T cells noncytopathically clear persistently infected microglia after conversion into antigen-presenting cellsT-cell tolerance: exposure to virus in utero does not cause a permanent deletion of specific T cellsLong-term CD4 Th1 and Th2 memory following acute lymphocytic choriomeningitis virus infectionInfection and inflammation in skeletal muscle from nonhuman primates infected with different genospecies of the Lyme disease spirochete Borrelia burgdorferi.Viral persistence in vivo through selection of neutralizing antibody-escape variants.Lentiviral transduction of dendritic cells confers protective antiviral immunity in vivoPersistence of lymphocytic choriomeningitis virus at very low levels in immune mice.DNA vaccination against persistent viral infection.Uncovering subdominant cytotoxic T-lymphocyte responses in lymphocytic choriomeningitis virus-infected BALB/c mice.A critical role for neutralizing-antibody-producing B cells, CD4(+) T cells, and interferons in persistent and acute infections of mice with lymphocytic choriomeningitis virus: implications for adoptive immunotherapy of virus carriers.Genetic basis of viral persistence: single amino acid change in the viral glycoprotein affects ability of lymphocytic choriomeningitis virus to persist in adult mice.T cell memory. Long-term persistence of virus-specific cytotoxic T cells.CD8 T cell memory in B cell-deficient mice.CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection.Molecular determinants of macrophage tropism and viral persistence: importance of single amino acid changes in the polymerase and glycoprotein of lymphocytic choriomeningitis virusMolecular anatomy of viral persistenceViral infection of the thymusRole of immune cells in protection against and control of reovirus infection in neonatal miceT-cell-mediated clearance of mouse hepatitis virus strain JHM from the central nervous systemT4+ T helper cell function in vivo: differential requirement for induction of antiviral cytotoxic T-cell and antibody responses.Genetic analysis of in vivo-selected viral variants causing chronic infection: importance of mutation in the L RNA segment of lymphocytic choriomeningitis virus.A novel virus carrier state to evaluate immunotherapeutic regimens: regulatory T cells modulate the pathogenicity of antiviral memory cellsThe great balancing act: regulation and fate of antiviral T-cell interactionsRequirement of B cells for generating CD4+ T cell memory.Lymphocytic choriomeningitis infection of the central nervous system.Persistent viral infection elevates central nervous system MHC class I through chronic production of interferons.Therapeutic memory T cells require costimulation for effective clearance of a persistent viral infection.PTPN22 contributes to exhaustion of T lymphocytes during chronic viral infection.Therapeutic depletion of natural killer cells controls persistent infection.Viral diseases of the next century.Evidence for an underlying CD4 helper and CD8 T-cell defect in B-cell-deficient mice: failure to clear persistent virus infection after adoptive immunotherapy with virus-specific memory cells from muMT/muMT mice.Antiviral cytotoxic T-cell memory by vaccination with recombinant Listeria monocytogenes.Progressive loss of memory T cell potential and commitment to exhaustion during chronic viral infection.CD40L-deficient mice show deficits in antiviral immunity and have an impaired memory CD8+ CTL response.Rous-Whipple Award Lecture. Viruses and diseases of the twenty-first century.Long-term persistence of activated cytotoxic T lymphocytes after viral infection of the central nervous system.
P2860
Q27308832-07995623-E579-4D67-8B53-36CDB2BA0637Q33564026-C0D988F5-1DBB-4683-9B4B-49101896C6B2Q33784950-D70EC727-46BC-41E2-AF3A-CB1D1E49FBE0Q34945178-D596CB3A-4F8B-42C9-B482-16CAFB2D6B99Q35080884-EBF740C3-4342-4630-AD78-5CD8F38D5616Q35122548-AD03DEAB-75A6-4DEB-9C1B-D2955AB70410Q35726474-9D14EB46-E1EA-4173-ABC8-B193609446E4Q35838136-5E5D1535-01B6-427E-A5CA-5FBD4B6F9C4CQ35887911-C03BE39B-633B-4747-B1B1-51BD87A8F50BQ36241631-25202AC1-9E2A-40A2-9F6E-A2B8F5F21EE4Q36353608-4EB0984C-CEAB-4F81-B856-8DD993798819Q36356494-6422CEED-BAFD-44F0-B333-9025DBFC8307Q36366705-5E325FEC-81EE-4F8D-8004-06B43A863806Q36637922-E8423E01-A250-476A-8292-C81689138DDBQ36655265-E36A1F3B-BE24-4974-88D2-F7B36C37865FQ36693882-F8C7144D-0C65-4D06-AF00-7A7A4D88FE39Q36697615-DA08C4DB-BB34-40F2-AD8E-C82EF5F939D5Q36797996-D92A12E0-17EF-4C85-B382-9E84520EB4DDQ36829349-9D6BDAAC-A441-4647-988A-E299DB60C9A5Q36869344-85B2A25C-4230-4EE8-8FCA-45514F821F10Q36872443-32E73CC7-26F3-49B6-A489-933D68FE97C3Q36981848-A61A12E9-214E-491B-BFD3-9E214D683B59Q37108443-24F894CC-74EB-4B5D-B61E-5AE5B5F60033Q37135496-A1AD877F-82A0-498F-B50C-D81B23233F09Q37175343-BF4D3EF1-17EF-45EF-ADEB-4BA05C6E5EFFQ37211494-C6ABF60F-B219-4007-B791-8D65B06BE2A1Q37333710-B688FF5B-B479-4282-B514-387D1030CD04Q37469344-3AA1EF24-B557-4F89-8DDF-8C3A97C22469Q37547157-C453027D-B312-4CF6-ABB0-E31F44851733Q38301641-2B7501A9-B81E-44AD-91E7-C0112D958864Q39582188-3518B834-68E2-4E27-AEB7-8D3528B2104AQ39874289-142B5694-00C4-4259-8197-AB3016428049Q41855937-D8EAAD48-3387-40A6-943D-E4CF122FF0EEQ41898717-37E3137C-797D-479A-8DC3-2B87FD2AC888Q42754542-28F69413-B2FF-4086-B469-7FE368514503Q42971627-524308B4-742B-440C-A649-95BF16784042
P2860
Immune therapy of a persistent and disseminated viral infection.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
1987年论文
@zh
1987年论文
@zh-cn
name
Immune therapy of a persistent and disseminated viral infection.
@en
type
label
Immune therapy of a persistent and disseminated viral infection.
@en
prefLabel
Immune therapy of a persistent and disseminated viral infection.
@en
P2093
P2860
P1433
P1476
Immune therapy of a persistent and disseminated viral infection
@en
P2093
P2860
P304
P407
P577
1987-12-01T00:00:00Z